Home The Word Brain My Amedeo FAQ Privacy About   

As of October 2023, Amedeo had
12,263 active subscribers

  Diseases of the Thyroid

  Free Subscription


1 Diagn Cytopathol
2 J Clin Endocrinol Metab
1 N Engl J Med
2 PLoS One
2 Surgery
6 Thyroid

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Diagn Cytopathol

  1. SURA GH, Thrall MJ, Rogers J, Hodjat P, et al
    A retrospective analysis of molecular testing in cytologically indeterminate thyroid nodules with histologic correlation: Experience at a heterogenous multihospital system.
    Diagn Cytopathol. 2023 Nov 10. doi: 10.1002/dc.25250.
    PubMed         Abstract available

    J Clin Endocrinol Metab

  2. LI P, Liu Y, Wei T, Wang X, et al
    Effect and interactions of BRAF on lymph node metastasis in papillary thyroid carcinoma with Hashimoto's thyroiditis.
    J Clin Endocrinol Metab. 2023 Nov 15:dgad667. doi: 10.1210.
    PubMed         Abstract available

  3. LAFONTAINE N, Shore CJ, Campbell PJ, Mullin BH, et al
    Epigenome-wide association study shows differential DNA methylation of MDC1, KLF9 and CUTA in autoimmune thyroid disease.
    J Clin Endocrinol Metab. 2023 Nov 14:dgad659. doi: 10.1210.
    PubMed         Abstract available

    N Engl J Med

  4. CASTINETTI F, Borson-Chazot F
    Thirty Years of Progress Thanks to the RET Oncogene.
    N Engl J Med. 2023;389:1916-1918.

    PLoS One

  5. KANANKULAM VELLIANGIRI S, Ballal S, Prasad Yadhav M, Tripathi M, et al
    A long-term retrospective cohort-based risk-benefit analysis of augmenting total cumulative I-131 activity to 37GBq in differentiated thyroid cancer patients with skeletal metastases.
    PLoS One. 2023;18:e0294343.
    PubMed         Abstract available

  6. HEO J, Lee S, Park J, Yang H, et al
    Age-associated mortality is partially mediated by TERT promoter mutation status in differentiated thyroid carcinoma.
    PLoS One. 2023;18:e0294145.
    PubMed         Abstract available


    Addressing financial toxicity in thyroid cancer survivors in the United States.
    Surgery. 2023 Nov 10:S0039-6060(23)00755-9. doi: 10.1016/j.surg.2023.

  8. RUSSELL JO, Desai DD, Noel JE, Hussein M, et al
    Radiofrequency ablation of benign thyroid nodules: A prospective, multi-institutional North American experience.
    Surgery. 2023 Nov 10:S0039-6060(23)00725-0. doi: 10.1016/j.surg.2023.
    PubMed         Abstract available


  9. MOOG S, Lamartina L, Bani MA, Al Ghuzlan A, et al
    Alkylating Agent-Induced High Tumor Mutational Burden in Medullary Thyroid Cancer and Response to Immune Checkpoint Inhibitors: Two Case Reports.
    Thyroid. 2023;33:1368-1373.
    PubMed         Abstract available

  10. BOROS E, Marcelis L, Van Vliet G, Elilie Mawa Ongoth F, et al
    Thyrotropin Screening of Newborns: Before or After 72 Hours of Life? Before Discharge or at Home?
    Thyroid. 2023;33:1311-1317.
    PubMed         Abstract available

  11. For more information and a current list of upcoming thyroid-related meetings, visit www.thyroid.org/professionals/meetings.
    Thyroid. 2023;33:1384.

  12. DOUGLAS RD, Parunakian E, Tolentino J, Malkhasyan E, et al
    A Prospective Study Examining Audiometry Outcomes Following Teprotumumab Treatment for Thyroid Eye Disease.
    Thyroid. 2023 Nov 14. doi: 10.1089/thy.2023.0466.
    PubMed         Abstract available

  13. TARASOVA VD, Tsai J, Masannat J, Hernandez-Prera J, et al
    Characterization of the thyroid cancer genomic landscape by plasma-based circulating tumor DNA next-generation sequencing.
    Thyroid. 2023 Nov 14. doi: 10.1089/thy.2023.0204.
    PubMed         Abstract available

  14. LI X, Peng C, Liu Y, Hu Y, et al
    Modified ACR TI-RADS and Modified AI TI-RADS for Thyroid Nodules: A Multicenter Retrospective Study.
    Thyroid. 2023 Nov 11. doi: 10.1089/thy.2023.0429.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Diseases of the Thyroid is free of charge.